Anne Marie Falk

Array ( [id] => 4353430 [patent_doc_number] => 06215040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'IL-5 transgenic mouse' [patent_app_type] => 1 [patent_app_number] => 9/155884 [patent_app_country] => US [patent_app_date] => 1998-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 80 [patent_no_of_words] => 23500 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/215/06215040.pdf [firstpage_image] =>[orig_patent_app_number] => 155884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529627 [patent_doc_number] => 20020136705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'PORCINE SPINAL CORD CELLS AND THEIR USE IN SPINAL CORD REPAIR' [patent_app_type] => new [patent_app_number] => 09/163272 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19399 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136705.pdf [firstpage_image] =>[orig_patent_app_number] => 09163272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631308 [patent_doc_number] => 06635624 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Nucleotide vector composition containing such vector and vaccine for immunization against hepatitis' [patent_app_type] => B1 [patent_app_number] => 09/146072 [patent_app_country] => US [patent_app_date] => 1998-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 6469 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635624.pdf [firstpage_image] =>[orig_patent_app_number] => 09146072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6453775 [patent_doc_number] => 20020129385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'MEDTHODS FOR IMPROVING LONG-TERM MEMORY STORAGE AND RETRIEVAL' [patent_app_type] => new [patent_app_number] => 09/135521 [patent_app_country] => US [patent_app_date] => 1998-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 32116 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20020129385.pdf [firstpage_image] =>[orig_patent_app_number] => 09135521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535852 [patent_doc_number] => 06337200 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Human telomerase catalytic subunit variants' [patent_app_type] => B1 [patent_app_number] => 09/128354 [patent_app_country] => US [patent_app_date] => 1998-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10903 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337200.pdf [firstpage_image] =>[orig_patent_app_number] => 09128354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7639956 [patent_doc_number] => 06395960 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Transgenic mice expressing human presenilin proteins' [patent_app_type] => B1 [patent_app_number] => 09/124523 [patent_app_country] => US [patent_app_date] => 1998-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 35758 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395960.pdf [firstpage_image] =>[orig_patent_app_number] => 09124523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242337 [patent_doc_number] => 20020045248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'INTRACELLULAR INHIBITORS OF GQ PROTEIN SIGNALING' [patent_app_type] => new [patent_app_number] => 09/121814 [patent_app_country] => US [patent_app_date] => 1998-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7160 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045248.pdf [firstpage_image] =>[orig_patent_app_number] => 09121814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6773799 [patent_doc_number] => 20030017137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'VPR-DRIVEN DNA OR RNA CONSTRUCT AND THERAPEUTIC USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/120286 [patent_app_country] => US [patent_app_date] => 1998-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6536 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017137.pdf [firstpage_image] =>[orig_patent_app_number] => 09120286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1171917 [patent_doc_number] => 06750025 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Method of detecting and isolating prion protein and variants thereof' [patent_app_type] => B1 [patent_app_number] => 09/112956 [patent_app_country] => US [patent_app_date] => 1998-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9752 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750025.pdf [firstpage_image] =>[orig_patent_app_number] => 09112956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1018015 [patent_doc_number] => 06890909 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Brain-protective agent' [patent_app_type] => utility [patent_app_number] => 09/446913 [patent_app_country] => US [patent_app_date] => 1998-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2328 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890909.pdf [firstpage_image] =>[orig_patent_app_number] => 09446913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4210877 [patent_doc_number] => 06028245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Transgenic animals overexpressing MDM2' [patent_app_type] => 1 [patent_app_number] => 9/104497 [patent_app_country] => US [patent_app_date] => 1998-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 32 [patent_no_of_words] => 10970 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028245.pdf [firstpage_image] =>[orig_patent_app_number] => 104497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392201 [patent_doc_number] => 06541247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Method of isolating ependymal neural stem cells' [patent_app_type] => B1 [patent_app_number] => 09/104772 [patent_app_country] => US [patent_app_date] => 1998-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 38 [patent_no_of_words] => 10508 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541247.pdf [firstpage_image] =>[orig_patent_app_number] => 09104772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1307993 [patent_doc_number] => 06613319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Long-term expression of erythropoietin and growth hormone by transforming muscle cells' [patent_app_type] => B2 [patent_app_number] => 09/091134 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8331 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613319.pdf [firstpage_image] =>[orig_patent_app_number] => 09091134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4210863 [patent_doc_number] => 06028244 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Defective platelet activation in G.alpha..sub.q deficient mice' [patent_app_type] => 1 [patent_app_number] => 9/096366 [patent_app_country] => US [patent_app_date] => 1998-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 9 [patent_no_of_words] => 10894 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028244.pdf [firstpage_image] =>[orig_patent_app_number] => 096366 [rel_patent_id] =>[rel_patent_doc_number] =>)